Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Roche presents HBsAg and HBV DNA production inhibitors

Nov. 22, 2016

Actelion Pharmaceuticals describes TPHI1 inhibitors

Nov. 22, 2016

Janssen R&D Ireland discloses agents for RSV infection

Nov. 22, 2016

Janssen Pharmaceutica patents TARPgamma8 inhibitors

Nov. 22, 2016

Laboratorios del Dr. Esteve presents dual sigma1 and mu-opioid receptor ligands

Nov. 21, 2016

Chinese scientists develop Nav1.7 channel blockers

Nov. 21, 2016

Shanghai Fochon Pharmaceutical describes CDK4/cyclin D1 and CDK6/cyclin D1 inhibitors

Nov. 21, 2016

University of North Carolina at Chapel Hill discloses anticancer agents

Nov. 21, 2016

Omeros patents PDE10A inhibitors

Nov. 21, 2016

Sanford-Burnham Medical Research Institute presents EphA4 inhibitors

Nov. 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...